Researchers from the University of Florida-Jacksonville, College of Medicine presented the results of a pilot study utilising LiquiBand® topical skin adhesive at the American College of Emergency Physicians (ACEP) Scientific Assembly in San Francisco, October 15-18, 2011. The study demonstrated the effectiveness of LiquiBand® in the closure of scalp lacerations.
Dermal adhesives are commonly used for facial wound repairs but are rarely used in the US for scalp wounds. LiquiBand® is a fast polymerizing, medical grade adhesive (cyanoacrylate) that has been successfully used in Europe for topical skin closure, including closing scalp wounds, for more than ten years. This is, however, the first study in the US that specifically addresses the use of dermal adhesives on scalp wounds. Emergency physicians measured ease-of-use, closure time, wound appearance and complications, while patients assessed wound appearance post-closure and pain levels during application.
The physicians involved in the study found that LiquiBand® treated scalp wounds very effectively, giving an average score of 4.67 out of 5. Patients reported very low pain scores during the procedures, and all parties indicated that they would use LiquiBand® again rather than traditional staples or sutures.
Commenting on this announcement, Chris Meredith, Chief Executive Officer of AMS commented: “This small pilot study clearly supports what we already knew, namely that LiquiBand® can be used safely for rapid closure of simple scalp lacerations with minimal pain and excellent cosmetic outcomes. However, the key aspect of this study is that it is the first of its kind in the US. The results pave the way for a larger prospective study to be undertaken, but we believe that the high levels of reported physician and patient satisfaction should give direct support to the already encouraging marketing initiatives of our partners in that key market.”
Source: Advanced Medical Solutions
published: October 24, 2011 in: Clinical Studies/Trials, Companies, News